At least three people needed hospitalization in February after taking veterinary-strength ivermectin, which has been touted -- without clinical evidence -- as a COVID-19 preventive, according to the FDA. The NIH is planning a randomized clinical trial to see if drugs approved for other uses can reduce COVID-19 symptoms, and ivermectin, fluvoxamine and famotidine are top candidates.
Ivermectin may get clinical trial for COVID-19
Sign up for Animal Health SmartBrief
News for animal health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.